Clopidogrel and omeprazole — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Reduced clopidogrel activation with omeprazole
This scenario assesses Clopidogrel and omeprazole in a UK pharmacy practice context. Omeprazole can inhibit CYP2C19 and reduce formation of clopidogrel’s active metabolite. The best answer is Reduced clopidogrel activation with omeprazole because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF; MHRA Drug Safety Update